NEWSpublisher 2007 :: AngloChinese Investments
SEARCH COMPANY
name:
trunover in millions USD:
from:    to: 
R & D turnover in millions USD:
from:     to: 
NET profit:
from:    to: 
employees:
from:    to: 
COMPANIES
APPROVALS
ACTIVITIES ENGAGED IN
R & D
CLINICAL TRIALS
NON CLINICAL & PRECLINICAL
CHEMISTRY-CONTRACT MANUFACTURE
TEST
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY DETAILS » Tianjin Institute Of Pharmaceutical Research—Ne back to previous page show list

Tianjin Institute Of Pharmaceutical Research—Ne

»
address: 308 Anshanxi Street
Nankai District,Tianjin
China
contact: tel:022-23006865
key person: Director
Changxiao Liu-Doctor Advisor

trunover in millions USD: 0
R & D turnover in millions USD: 0
NET profit: 0
year of financial results:
employees: 0

active in China: YES

SFDA approved: YES
SFDA approved date: 29/03/2007

Approvals:
GLP: YES
GMP: NO
AAALAC: NO
SEPA: NO

Activities engaged in:
Manufacture: NO
Active Pharmaceutical: NO
R&D: NO
Ingredients: NO
Western Generics: NO
TCM: NO

R & D:
Discovery: NO
Work Up (pilot to production): NO
Analysis: NO
Quality Control: NO
Stability: NO
Batch Release: NO

Clinical trials:
Run/Manage: NO
Data management: YES
Support Labs: YES

Non clinical & preclinical:
Animal Testing: GLP: YES
New materials Safety Assessment: YES
Pharmaceuticals: YES
Agrochemicals: NO
Industrial & Other Chemicals: NO
Non GLP - Discovery ADME: YES

Chemistry-contract manufacture:
Generics: NO
API: NO
Licensed Drugs: NO

test:
R&D: NO
 
Tianjin Institute Of Pharmaceutical Research—New Drug Safety Evaluation Center mainly carry out the following preclinic research: Pharmacology, toxicology, Pharmacokinetics, drug evaluation of bioengineering .
 
The center has 56 staff, three Phd and nine received master degree.
 
Main responsibility:
Drug safety evaluation: with the GLP standard to do nonclinical research of chemical drug,TCM and biodrug.
 
Pharmacology study: the center focus on the Pharmacology of heart and blood vessel drug, mainly include: Dissolve Embolism Drugs, anti-embolism drugs, anti-myocardial ischemia drug, anti-cerebral Ischemic drug, anti-heart failure drugs, anti-coagulation drug, anti hypertensive drug. They also study the Pharmacology of TCM, anti-inflammatory drugs, respiratory drug, Digestive System drug etc.
 
Pharmacokinetics study: carry out the preclinical research and  toxic-kinetics study, supply preclinical research material to clinic trial study; cooperate with the clinic trial base to study the effect of the new drug.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.